Clinical Trial Update: Orlistat for the Treatment of Type I Hyperlipoproteinemia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating orlistat for treating Hyperlipoproteinemia Type I and related hypertriglyceridemia conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type
• Hypertriglyceridemia

Drugs mentioned

• Orlistat (orlistat)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hyperlipoproteinemia Type I, Hypertriglyceridemia | Phase 2 | Status: COMPLETED | Results posted: 2019-02-01